SubsidieMeestersFlowAssist Pouch will help to improve the skin condition of ostomy pouch users, while introducing novel design features, dramatically improving their lifestyle and management of their condition
Ostoform's FLOWASSIST technology combines non-absorbent and hydrocolloid materials to enhance ostomy pouch performance, reduce skin complications, and expand market opportunities.
Projectdetails
Introduction
Ostoform has developed and patented a new Class I medical technology, FLOWASSIST, by combining a non-absorbent material with an absorbent material (hydrocolloid).
Technology Overview
The non-absorbent material comprises a flexible spout, positioned beneath the patient's stoma, and is combined with hydrocolloid adhesive to keep the spout in place.
Hybrid Design Benefits
This hybrid design directs stoma output away from the patient's skin and into the pouch. The spout prevents output from being absorbed, so the hydrocolloid material does not break down.
- This means that the appliance lasts longer.
- The skin is protected for longer.
- The risk of leaks and skin complications is significantly reduced.
Commercialization
The Ostoform Seal with FLOWASSIST has been successfully developed and commercialized through the H2020 SME Instrument.
Future Plans
Ostoform now plans to develop the Ostoform Pouch with the same FLOWASSIST technology. As the ostomy pouch market is larger than the seal market, the novel pouch will increase market opportunity and company value.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.901 |
| Totale projectbegroting | € 3.571.287 |
Tijdlijn
| Startdatum | 1-1-2023 |
| Einddatum | 31-12-2024 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- OSTOFORM LIMITEDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Temporary intraluminal bypass device designed to reduce the rate of diverting stoma and its related complication by at least 70%The CG-100 device aims to prevent anastomotic leakage in colorectal surgery by creating an internal bypass, improving patient quality of life and reducing healthcare costs significantly. | EIC Accelerator | € 2.269.312 | 2022 | Details |
Saving patients from severe heart failureThe ICOMS FlowMaker® is a novel intracardiac assist device designed to improve the quality of life for severe heart failure patients, aiming for EU market entry by 2026 through clinical trials. | EIC Accelerator | € 2.500.000 | 2022 | Details |
An innovative implantable device and management platform to prevent chronic fluid congestionFILBERT is an implantable peritoneal ultrafiltration system that enables continuous fluid management for diuretic-resistant CHF patients, improving quality of life and reducing healthcare costs. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary IncontinenceDeveloping UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patientsThe Inossia Cement Softener reduces bone cement stiffness by 50-75%, improving vertebral augmentation outcomes and significantly lowering fracture risks in osteoporotic patients. | EIC Accelerator | € 2.298.325 | 2023 | Details |
Temporary intraluminal bypass device designed to reduce the rate of diverting stoma and its related complication by at least 70%
The CG-100 device aims to prevent anastomotic leakage in colorectal surgery by creating an internal bypass, improving patient quality of life and reducing healthcare costs significantly.
Saving patients from severe heart failure
The ICOMS FlowMaker® is a novel intracardiac assist device designed to improve the quality of life for severe heart failure patients, aiming for EU market entry by 2026 through clinical trials.
An innovative implantable device and management platform to prevent chronic fluid congestion
FILBERT is an implantable peritoneal ultrafiltration system that enables continuous fluid management for diuretic-resistant CHF patients, improving quality of life and reducing healthcare costs.
Restoring a normal life and dignity for women and men suffering from severe Stress Urinary Incontinence
Developing UroActive™, a smart artificial urinary sphincter that offers a safe, convenient, and effective solution for severe urinary incontinence, minimizing side effects and restoring patient dignity.
Inossia Cement Softener - a new and unique additive to bone cements to revolutionise the treatment of vertebral fractures in osteoporotic patients
The Inossia Cement Softener reduces bone cement stiffness by 50-75%, improving vertebral augmentation outcomes and significantly lowering fracture risks in osteoporotic patients.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Ontwikkeling iFLOAT OTOHet project ontwikkelt de iFLOAT OTO, een innovatieve armondersteuning die via sensoren de bewegingen van gebruikers met progressieve spierziekten intuïtief volgt, waardoor hun zelfstandigheid en zorgontlasting toenemen. | Mkb-innovati... | € 325.325 | 2023 | Details |
Self Supporting SoxOnderzoek naar een compressiezwachtel die zelfstandig aan te brengen en uit te trekken is voor mensen zonder hulpmiddelen. | Mkb-innovati... | € 31.500 | 2020 | Details |
Bioactive Tissue Sealant for Enhanced Wound RepairBioTisSeal aims to create bioactive tissue sealants using gelatin methacryloyl and aptamers for enhanced wound healing and market readiness, addressing current limitations in wound care. | ERC Proof of... | € 150.000 | 2022 | Details |
Regenerative Stenting for Osteoporotic Vertebral Fracture RepairRESTORE aims to revolutionize osteoporotic vertebral fracture treatment by using 3D-printed biodegradable stents and thermoresponsive hydrogels for personalized bone regeneration and repair. | ERC Consolid... | € 2.039.473 | 2024 | Details |
Automatiseren peroperatieve bepaling immuniteitslevel (IMMUNOFLOW)Het IMMUNOFLOW-project ontwikkelt een algoritme voor snelle analyse van flowcytometriedata om artsen te helpen bij het tijdig starten van preventieve immuunbehandelingen na trauma-operaties. | Mkb-innovati... | € 20.000 | 2021 | Details |
Ontwikkeling iFLOAT OTO
Het project ontwikkelt de iFLOAT OTO, een innovatieve armondersteuning die via sensoren de bewegingen van gebruikers met progressieve spierziekten intuïtief volgt, waardoor hun zelfstandigheid en zorgontlasting toenemen.
Self Supporting Sox
Onderzoek naar een compressiezwachtel die zelfstandig aan te brengen en uit te trekken is voor mensen zonder hulpmiddelen.
Bioactive Tissue Sealant for Enhanced Wound Repair
BioTisSeal aims to create bioactive tissue sealants using gelatin methacryloyl and aptamers for enhanced wound healing and market readiness, addressing current limitations in wound care.
Regenerative Stenting for Osteoporotic Vertebral Fracture Repair
RESTORE aims to revolutionize osteoporotic vertebral fracture treatment by using 3D-printed biodegradable stents and thermoresponsive hydrogels for personalized bone regeneration and repair.
Automatiseren peroperatieve bepaling immuniteitslevel (IMMUNOFLOW)
Het IMMUNOFLOW-project ontwikkelt een algoritme voor snelle analyse van flowcytometriedata om artsen te helpen bij het tijdig starten van preventieve immuunbehandelingen na trauma-operaties.